Premium
Prognostic significance of interim 11 C ‐methionine PET for the treatment of primary central nervous system lymphoma ( PCNSL )
Author(s) -
Yang D.,
Kwon S.,
Yhim H.,
Park B.,
Park Y.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2439_35
Subject(s) - medicine , primary central nervous system lymphoma , chemotherapy , lymphoma , cytarabine , diffuse large b cell lymphoma , methotrexate , survival analysis , receiver operating characteristic , oncology , gastroenterology , nuclear medicine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom